Today: 10 June 2026
ARB share price dives 13% after profit slides; ASX:ARB outlook and April dividend in focus
24 February 2026
2 mins read

ARB share price dives 13% after profit slides; ASX:ARB outlook and April dividend in focus

Sydney, Feb 24, 2026, 18:37 (AEDT) — Trading has moved into after-hours.

  • ARB dropped roughly 13%, landing at A$21.36.
  • Profit before tax for the first half slid almost 19%, with revenue also ticking down.
  • The interim dividend stays at 34 cents per share, with April 2 as the record date.

Shares in ARB Corporation Limited tumbled 13.1% Tuesday after the company posted a steep drop in first-half earnings and revealed new headwinds from margin squeeze, blaming currency moves and higher factory outlays. The stock changed hands at A$21.36, down A$3.21 for the session.

Why does it matter? ARB’s profits track vehicle sales and aftermarket appetite, but with much of its product coming out of Thailand, a softer Australian dollar versus the baht eats into margins. Traders are also eyeing whether ARB can loosen fitment and capacity bottlenecks—without chewing up returns in the process.

Management is attempting to soothe concerns about the back half, citing currency hedges and more stable recovery of factory costs. Still, they flagged persistent tightness in new-vehicle supply and lingering uncertainty in consumer sentiment.

ARB reported in a Feb. 24 ASX filing that first-half sales revenue edged down 1% to A$358.0 million. Profit before tax slid 18.8% to A$57.1 million. Net profit after tax fell 17.2%, landing at A$42.2 million. Stripping out one-off items, underlying net profit came in at A$43.2 million—a 14.4% drop.

The company blamed the drop largely on “reduced sales margins” tied to the softer Australian dollar and less factory overhead recovery, pointing out that a lot of its expenses are in Thai baht. According to the company, most of its Thai baht exposure for the second half is hedged at “slightly more favourable” rates, and it’s expecting second-half sales margins to roughly match those from the same period last year.

Damage wasn’t spread evenly. ARB flagged a 1.7% drop in Australian aftermarket sales, blaming softer new-vehicle sales on major platforms and not enough accessory fitment resources. Exports, though, climbed 8.8%, with the U.S. surging 26.1%. Sales to OEMs—the automakers ARB supplies—tumbled 38.2%. The company had expected a slump there, but not to this extent.

The company described demand as stuck rather than gone. Open orders finished the period up 5% from a year ago, it said. Store expansion continued, with more site changes and new openings also on the agenda.

ARB is keeping its interim dividend unchanged at 34 Australian cents per share, fully franked. The record date is April 2, and shareholders are set to receive payment on April 17. Dividend reinvestment and bonus share plans will be available for this interim distribution.

The company pointed to its strong balance sheet—A$59.4 million in cash, zero debt as of Dec. 31. Operating cash flow climbed as well, reaching A$63.9 million for the half.

Looking ahead, ARB is projecting a stronger second half, aiming for results that move nearer to last year’s comparable stretch. The company still calls the Australian aftermarket “challenging,” blaming vehicle supply and fitment issues. Export demand, especially in the U.S., should remain strong, according to ARB, and OEM sales are seen as “marginally better” than the first half.

Australian stocks barely budged on Tuesday, with the S&P/ASX 200 closing flat as traders kept to the sidelines, wary ahead of consumer price figures due Wednesday, according to a Reuters market update.

Still, things could unravel in a few clear ways. A stronger Thai baht, or continued tightness in new-vehicle supply, threatens to stall ARB’s recovery on both margin and volume. And if carmakers keep chipping away at inventory, the OEM slump might just stick around.

Stock Market Today

  • Apotex Debuts on Toronto Stock Exchange in Largest Life Sciences IPO
    June 10, 2026, 10:06 AM EDT. The Toronto Stock Exchange (TSX) welcomed Apotex Health Corp., marking the largest life sciences initial public offering (IPO) by total proceeds on the exchange, raising $1.3 billion. Apotex, a Canadian global health company, began trading under the symbol APTX on June 11, 2026. The listing reflects the strength of Canadian capital markets and underscores growth in the life sciences sector, which counts 110 companies listed on TSX and TSX Venture Exchange with a combined market capitalization of $26 billion. Apotex provides a wide range of affordable medicines including generics and biosimilars, serving millions worldwide from its Toronto headquarters and global offices. TSX CEO Loui Anastasopoulos praised the listing as showcasing Canadian competitiveness on the global stage.

Latest articles

Rigetti Computing Stock Falls as Sale Notice Tests $100 Million Quantum Rally

Rigetti Computing Stock Falls as Sale Notice Tests $100 Million Quantum Rally

10 June 2026
Rigetti Computing plunged 9.55% to $19.69 Tuesday and dipped further premarket after director Ray O. Johnson filed to sell 122,188 shares worth $2.6 million, testing investor confidence following a recent rally on news of a potential $100 million U.S. Commerce Department quantum-computing award, with traders watching for binding funding terms amid ongoing volatility.
PATH slips again, investors keep questioning AI automation bet

PATH slips again, investors keep questioning AI automation bet

10 June 2026
UiPath shares slid 3.76% to $10.75 and dropped another 1.49% pre-market as investors focused on slowing annual recurring revenue growth—up 12% to $1.901 billion versus 17% revenue growth—raising doubts about AI automation’s impact on recurring sales; second-quarter ARR guidance of $1.929–$1.934 billion is now the key number for PATH’s stock direction.
Eli Lilly stock pops after Novo trial miss, new Zepbound pen gets FDA nod
Previous Story

Eli Lilly stock pops after Novo trial miss, new Zepbound pen gets FDA nod

National Grid share price ticks up as Ofgem flags AI data-centre power crunch
Next Story

National Grid share price ticks up as Ofgem flags AI data-centre power crunch

Go toTop